EarningsQ3 2024 Earnings Report

Novartis (NVSN) Q3 2024 Earnings Report

0 Followers

MX:NVSN Q3 2024 EPS Results

Actual EPS$37.41

Consensus EPS$35.20

Beat/MissBeat by +$2.22

One Year Ago EPS$31.60

Actual Revenue$235.42B

Expected Revenue$232.32B

Beat/MissBeat by +$3.10B

YoY Revenue Growth+10.52%

QuarterQ3 2024

Date10/29/2024

TimeBefore Open

Conference CallTuesday, October 29, 2024

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	41.10 / -	40.863	―
Jul 21, 2026	2026 (Q2)	39.45 / 43.77	43.95	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	38.10 / 36.14	41.408	-12.72% (-5.27)
Feb 04, 2026	2025 (Q4)	36.01 / 36.87	35.959	2.53% (+0.91)
Oct 28, 2025	2025 (Q3)	41.28 / 40.86	37.412	9.22% (+3.45)
Jul 17, 2025	2025 (Q2)	42.70 / 43.95	35.778	22.84% (+8.17)
Apr 29, 2025	2025 (Q1)	38.39 / 41.41	32.69	26.67% (+8.72)
Jan 31, 2025	2024 (Q4)	32.78 / 35.96	27.787	29.41% (+8.17)
Oct 29, 2024	2024 (Q3)	35.20 / 37.41	31.601	18.39% (+5.81)
Jul 18, 2024	2024 (Q2)	33.60 / 35.78	31.492	13.61% (+4.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed